Hirtle Callaghan & CO LLC Merck & Co., Inc. Transaction History

Hirtle Callaghan & CO LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	BUY	$102.95 - $114.33 $18,222 - $20,236	177 Added 6.6%	2,858 $294,000
Q2 2023 Aug 10, 2023	SELL	$108.61 - $118.38 $83,412 - $90,915	-768 Reduced 22.27%	2,681 $309,000
Q1 2023 May 11, 2023	BUY	$102.94 - $114.86 $355,040 - $396,152	3,449 New	3,449 $366,000
Q1 2019 May 14, 2019	SELL	$69.58 - $79.36 $591,430 - $674,560	-8,500 Closed	0 $0
Q4 2017 Jan 17, 2018	SELL	$51.62 - $61.64 $9,498 - $11,341	-184 Reduced 2.12%	8,500 $478,000
Q3 2017 Nov 13, 2017	BUY	$58.67 - $63.13 $509,490 - $548,220	8,684	8,684 $556,000

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Hirtle Callaghan & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Hirtle Callaghan & CO LLC with notifications on news.